tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

PRTA Stock Latest News

Prothena price target lowered to $20 from $24 at RBC Capital
The FlyProthena price target lowered to $20 from $24 at RBC Capital
24h ago
PRTA
Promising Potential of Birtamimab in Transforming AL Amyloidosis Treatment: Analyst Recommends Buy
PremiumRatings
Promising Potential of Birtamimab in Transforming AL Amyloidosis Treatment: Analyst Recommends Buy
1d ago
PRTA
PRTA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PRTA Upcoming Earnings Report: What to Expect?
11d ago
PRTA
Prothena price target raised to $62 from $58 at Oppenheimer
PremiumThe Fly
Prothena price target raised to $62 from $58 at Oppenheimer
15d ago
PRTA
Prothena initiated with a Buy at Chardan
PremiumThe Fly
Prothena initiated with a Buy at Chardan
2M ago
PRTA
Prothena price target lowered to $48 from $84 at H.C. Wainwright
PremiumThe FlyProthena price target lowered to $48 from $84 at H.C. Wainwright
2M ago
PRTA
RBC sees justification for Prothena rebound after study miss
Premium
The Fly
RBC sees justification for Prothena rebound after study miss
2M ago
PRTA
Prothena price target lowered to $22 from $26 at BofA
Premium
The Fly
Prothena price target lowered to $22 from $26 at BofA
2M ago
PRTA
Prothena price target lowered to $58 from $62 at Oppenheimer
PremiumThe Fly
Prothena price target lowered to $58 from $62 at Oppenheimer
2M ago
PRTA
Capricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025
PremiumThe Fly
Capricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025
2M ago
CAPR
GILD
Prothena partner Roche PADOVA study misses primary endpoint
PremiumThe Fly
Prothena partner Roche PADOVA study misses primary endpoint
2M ago
PRTA
Prothena Corporation Reports Q3 2024 Financial Results
PremiumCompany Announcements
Prothena Corporation Reports Q3 2024 Financial Results
3M ago
PRTA
Prothena reports Q3 EPS ($1.10), consensus ($1.18)
PremiumThe FlyProthena reports Q3 EPS ($1.10), consensus ($1.18)
3M ago
PRTA
PRTA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PRTA Earnings this Week: How Will it Perform?
4M ago
PRTA
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
KZR
BGNE
Prothena price target lowered to $31 from $33 at BofA
PremiumThe Fly
Prothena price target lowered to $31 from $33 at BofA
5M ago
PRTA
Prothena selloff ‘misplaced,’ brings buying opportunity, says H.C. Wainwright
PremiumThe Fly
Prothena selloff ‘misplaced,’ brings buying opportunity, says H.C. Wainwright
5M ago
PRTA
Prothena’s downside move may be excessive, says RBC Capital
PremiumThe Fly
Prothena’s downside move may be excessive, says RBC Capital
5M ago
PRTA
Oppenheimer says Prothena’s Garren left for ‘amazing opportunity’
PremiumThe Fly
Oppenheimer says Prothena’s Garren left for ‘amazing opportunity’
5M ago
PRTA
Prothena sinks 20% to $16.11 following exit of Chief Medical Officer
PremiumThe FlyProthena sinks 20% to $16.11 following exit of Chief Medical Officer
5M ago
PRTA
Prothena’s pipeline milestones coming into focus, says Cantor Fitzgerald
Premium
The Fly
Prothena’s pipeline milestones coming into focus, says Cantor Fitzgerald
5M ago
PRTA
Prothena Leadership Transition Amid Neurodegenerative R&D Push
Premium
Company Announcements
Prothena Leadership Transition Amid Neurodegenerative R&D Push
5M ago
8K
PRTA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >